Last reviewed · How we verify
Total intravenous anesthesia with Byfavo
At a glance
| Generic name | Total intravenous anesthesia with Byfavo |
|---|---|
| Sponsor | Yonsei University |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Hemodynamic Effects of Remimazolam vs Propofol During Robot-assisted Gynecologic Surgery (NA)
- Comparison of the Coughing Frequency of Remimazolam Total Intravenous Anesthesia Versus Inhalational Anesthesia (NA)
- Effect of Remimazolam and Propofol on Hemodynamic Stability During Anesthesia Induction in OPCAB Patients (NA)
- Comparison of Recovery From General Anesthesia in Remimazolam With Flumazenil vs. Propofol (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Total intravenous anesthesia with Byfavo CI brief — competitive landscape report
- Total intravenous anesthesia with Byfavo updates RSS · CI watch RSS
- Yonsei University portfolio CI